Metabolic and systemic heart diseases represent a complex intersection of multiple physiological systems, where conditions such as diabetes, obesity, and hypertension can significantly impact cardiovascular health. These systemic diseases often lead to changes in heart function, contributing to conditions like heart failure, coronary artery disease, and arrhythmias. Understanding the links between metabolic imbalances and cardiovascular outcomes is crucial for developing effective treatment strategies. Metabolic and systemic heart diseases require a multidisciplinary approach that combines pharmacological interventions, lifestyle modifications, and targeted therapies to address the root causes. By focusing on managing underlying metabolic conditions, healthcare providers can significantly reduce the risk of heart-related complications and improve long-term cardiovascular health.
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation